Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CG | P48736 | 1/20 | 0.36 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.33 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.31 |
| ▸ | EGFR | P00533 | 4/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21657921 | 0.93 | PIK3CG (0.36) | PIK3CGCYP11B1CYP11B2ALDH1A1CYP1A2 | |
| SCHEMBL8023101 | 0.87 | PIK3CG (0.38) | PIK3CGCYP11B1CYP11B2EGFR | |
| SCHEMBL30792962 | 0.84 | PIK3CG (0.35) | PIK3CGCYP11B1CYP11B2ALDH1A1CYP1A2 | |
| Phosphoric Acid SCHEMBL6557342 | 0.81 | PIK3CG (0.36) | PIK3CG | |
| SCHEMBL30290978 | 0.81 | PIK3CG (0.41) | PIK3CGALDH1A1CYP1A2CYP3A4CYP2C9 | |
| SCHEMBL2490862 | 0.81 | PIK3CG (0.41) | PIK3CGALDH1A1CYP1A2CYP3A4CYP2C9 | |
| SCHEMBL22792590 | 0.75 | PIK3CG (0.33) | PIK3CG | |
| SCHEMBL3292267 | 0.73 | PIK3CG (0.47) | PIK3CGALDH1A1CYP1A2CYP3A4CYP2C9 | |
| SCHEMBL18882007 | 0.71 | BCHE (0.39) | ALDH1A1CYP3A4 | |
| SCHEMBL1378685 | 0.71 | PIK3CG (0.46) | PIK3CGALDH1A1CYP1A2CYP3A4CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10550116-B2 | Fused bicyclic heterocycle derivatives as pesticides | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2020-02-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10550116-B2 | Fused bicyclic heterocycle derivatives as pesticides | DDT, BCHE, ACHE | PIK3CG 1356/4885CYP11B1 121/4885CYP11B2 125/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.